Global Health Delivers Strong Q2 FY27 With 60% EBITDA Growth
Global Health Ltd 路 Press Release 路 03 Nov 2026, 10:45 pm
Global Health Delivers Strong Q2 FY27 With 60% EBITDA Growth Global Health (Medanta) reported robust Q2 FY27 results, with revenue from operations rising 33.6% YoY to INR 14,690 million and operating EBITDA jumping 60.2% YoY to INR 3,701 million as margins expanded 418 bps to 25.2%. PAT grew 38.3% YoY to INR 2,191 million. Operational beds reached 3,115 with 67% occupancy, driven by inpatient volume growth of 29.5% YoY. Noida hospital achieved EBITDA breakeven at INR 86 million. The board approved a new 500-bed greenfield hospital in Ghaziabad with an estimated capex of ~INR 9,970 million.
Original exchange filing (PDF)
More announcements from Global Health Ltd
- Intimation of Credit Rating by Crisil. 路 18 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 18 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 16 Nov 2026
- Investor Presentation for the Analyst/Investors Meet . 路 14 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
- Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet. 路 10 Nov 2026
